Alamar Biosciences Inc (NAS:ALMR)
$ 36.02 +4 (+12.49%) Market Cap: 2.50 Bil Enterprise Value: 2.29 Bil PE Ratio: 0 PB Ratio: 7.99 GF Score: 12/100

Alamar Biosciences Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 15, 2026 / 08:05PM GMT
Release Date Price: $28.75 (+2.72%)
Unidentified Participant

Thank you very much for everyone for being here. It's my pleasure to have the Alamar team with us here today.

Yuling Luo, the Chief Executive Officer; and Justin McAnear, the Chief Financial Officer. So Yuling, Justin, welcome.

Justin McAnear
Alamar Biosciences Inc - Chief Financial Officer

Thank you.

Questions & Answers

Unidentified Participant

So maybe just to start off, for an investor that might be new to the Alamar story. What's the best way to understand where the company is at today and kind of how you fit into the broader ecosystem?

Yuling Luo
Alamar Biosciences Inc - Founder, Chairman of the Board, Chief Executive Officer

Alamar is establishing a gold standard in protein detection and analysis. We all know proteomics has huge potential to improve our understanding of health and disease, leading to better treatment and healthcare life. Despite all the great problems, this market remains to be largely untapped, mainly due to the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot